{
 "topic": "Fragile X Syndrome",
 "slug": "fragile-x-syndrome",
 "category_id": 15707,
 "summary": "Fragile X syndrome: the FMR1 CGG-repeat mechanism and genetic anticipation, why physical features and macro-orchidism appear late, and the case for early molecular testing over exam-based screening.",
 "written_by": "claude-sonnet",
 "references": [
  {
   "title": "Cover",
   "author": "Vitalsource Download",
   "pages": [
    2603
   ]
  },
  {
   "title": "Pediatric Dentistry: Infancy through Adolescence - Arthur J. Nowak, John R. Christensen, Tad R. Mabry, Janice A. Townsend, Martha H. Wells - 6th Edition (2018) 656 pp., ISBN: 978-0-323-60826-8",
   "author": "Arthur J. Nowak, John R. Christensen, Tad R. Mabry, Janice A. Townsend, Martha H. Wells",
   "pages": [
    295
   ]
  },
  {
   "title": "Pediatric Clinical Practice Guidelines & Policies, 18th Edition",
   "author": "American Academy of Pediatrics",
   "pages": [
    1268
   ]
  },
  {
   "title": "Pediatric Clinical Practice Guidelines and Policies",
   "author": "American Academy of Pediatrics (AAP);",
   "pages": [
    1294
   ]
  },
  {
   "title": "Pediatric Board Study Guide",
   "author": null,
   "pages": [
    1041
   ]
  },
  {
   "title": "Kliegman R. Nelson Textbook of Pediatrics 2-Volume Set 22ed 2024",
   "author": null,
   "pages": [
    432,
    3532
   ]
  },
  {
   "title": "CURRENT Diagnosis and Treatment Pediatrics, Twenty-Fourth Edition",
   "author": "Hay, William W., Levin, Myron J., Deterding, Robin R., Abzug, Mark J.",
   "pages": [
    128,
    1149
   ]
  },
  {
   "title": "AAP Developmental and Behavioral Pediatrics",
   "author": "AAP Section on Developmental and Behavioral Pediatrics,Robert G. Voigt,Michelle M. Macias ,Scott M. Myers ,Carl D Tapia",
   "pages": [
    30,
    38,
    65
   ]
  }
 ],
 "short": [
  {
   "title": "In short",
   "content": "- Fragile X syndrome is the most common inherited (monogenic) cause of intellectual disability and a common cause of autism spectrum disorder, caused by a CGG trinucleotide repeat expansion in the 5' untranslated region of the FMR1 gene on the X chromosome (Xq27.3).\n- Normal individuals have 6-50 CGG repeats; 50-200 repeats (the premutation) is associated with mild intellectual disability and other abnormalities; more than 200 repeats (the full mutation) causes classic fragile X syndrome via gene methylation that silences FMR1 transcription and causes FMR1 protein deficiency.\n- The premutation (50-200 repeats) occurs in about 1 in 1,000 white males; the full pathogenic variant occurs in about 1 in 4,000-8,000.\n- The repeat can lengthen when passed through the maternal germline (genetic anticipation), so a premutation can only expand to a full mutation when transmitted by the mother; males with the mutation are hemizygous (X-linked).\n- Classic facial/physical features - long face, prominent forehead, prognathism, large ears, relative macrocephaly - usually do not fully develop until the second decade of life, making early physical recognition difficult; boys with developmental delay should be strongly considered for molecular (fragile X DNA) testing regardless of physical appearance.\n- Macro-orchidism is a cardinal feature in males, reaching 40-50 mL after puberty; it is rare before age 6 and most affected males have testicular volume over 3 mL by ages 8-10.\n- About 20% of affected males meet criteria for autism spectrum disorder; other features include hyperextensible joints, mitral valve prolapse, gaze aversion, perseverative language, hand biting, and marked hypersensitivity to environmental stimuli. Full-mutation males typically have moderate intellectual disability (average IQ around 41).\n- Girls can also be affected (about 30% of girls with the full mutation have cognitive effects) because they have a second X chromosome producing some FMR1 protein, so are generally more mildly affected than boys; the female carrier phenotype ranges from normal IQ to intellectual disability, sometimes with autism-spectrum behaviors.\n- Family members carrying a premutation can have related conditions including premature ovarian failure and fragile X-associated tremor/ataxia syndrome, so family history is critical for diagnosis, genetic counseling, and management.\n"
  }
 ],
 "long": [
  {
   "title": "Definition",
   "content": "Fragile X syndrome (FXS) is an X-linked disorder caused by amplification (expansion) of a polymorphic CGG trinucleotide repeat in the 5' untranslated region of the FMR1 (fragile X mental retardation 1) gene. It is the most common monogenic (inherited) cause of intellectual disability and a common cause of autism spectrum disorder.\n"
  },
  {
   "title": "Epidemiology",
   "content": "In unaffected individuals, the FMR1 gene contains 6-50 CGG repeats. A premutation of 50-200 repeats is present in about 1 in 1,000 white males, while the full pathogenic variant (more than 200 repeats) occurs in about 1 in 4,000-8,000. Fragile X syndrome is documented as the cause of intellectual disability in almost 6% of males with intellectual disability.\n"
  },
  {
   "title": "Pathophysiology",
   "content": "FMR1 encodes an RNA-binding protein (FMRP) that is highly expressed in brain and testis and regulates metabotropic glutamate receptor 5. A premutation (50-200 CGG repeats) is associated with mild intellectual disability and other abnormalities. A full mutation (over 200 repeats) triggers methylation of the FMR1 gene promoter, which silences gene transcription and results in deficient FMRP production - the mechanism underlying the full syndrome. In rare cases the expanded gene escapes methylation, allowing some FMRP to still be produced and resulting in milder symptoms - illustrating fragile X as a model of epigenetic disease. The trinucleotide repeat can lengthen (expand) when passed through the maternal germline, a phenomenon called genetic anticipation, meaning a premutation can only convert to a full mutation when transmitted by a mother, not a father. Because FMR1 is X-linked, affected males are hemizygous for the mutation (carrying only the one, mutated copy), while females carry a second, typically normal, X chromosome that can still produce some FMRP - explaining why females are generally more mildly affected.\n"
  },
  {
   "title": "Clinical Features",
   "content": "The characteristic adult phenotype usually does not fully develop until the second decade of life, making early physical recognition difficult; this is a key reason boys with developmental delay should be strongly considered for molecular testing regardless of physical appearance. When present, distinguishing craniofacial features include relative macrocephaly, a long face with a prominent forehead, prognathism (a large jaw), and large ears. Macro-orchidism is a cardinal feature in affected males, typically becoming apparent around puberty and reaching 40-50 mL testicular volume after puberty; it is rarely seen in boys younger than 6 years, though most affected males have testicular volumes over 3 mL by 8-10 years of age. Other physical findings include hyperextensible joints and mitral valve prolapse. Behaviorally, children with fragile X syndrome often present in early childhood with developmental delay, social anxiety, hyperactivity, and difficult behavior; most affected males have intellectual disability with gaze aversion, perseverative language, hand biting, and marked hypersensitivity to environmental stimuli, and about 20% of males meet criteria for autism spectrum disorder. Full-mutation males typically have moderate intellectual disability, with an average IQ around 41. Girls with a full mutation can range from normal IQ to intellectual disability, with about 30% of girls with the full mutation showing cognitive effects, and can also show autism-spectrum behaviors, though generally more mildly than affected males. Clinical expression differs depending on which parent transmits the gene, related to the anticipation phenomenon described above.\n"
  },
  {
   "title": "Diagnostics",
   "content": "DNA analysis (fragile X molecular/CGG-repeat testing) is the reliable, definitive test for both prenatal and postnatal diagnosis and is considered the best test to confirm the diagnosis; it also facilitates genetic counseling. Because physical features are often not apparent until later childhood or adolescence, molecular testing should not be withheld based on a normal physical exam alone in a boy with unexplained developmental delay. Family history is critical, since multiple family members can be affected by intellectual disability or related premutation-associated conditions such as premature ovarian failure and fragile X-associated tremor/ataxia syndrome; the diagnosis in one child has significant implications for other family members as well.\n"
  },
  {
   "title": "Management",
   "content": "Management of fragile X syndrome requires a multidisciplinary approach focused on monitoring and managing developmental and behavioral symptoms. Beyond routine health supervision with a primary care clinician, many children benefit from ongoing care with a clinician experienced in fragile X syndrome, along with access to educational and behavioral health resources in the community. Age-related health supervision guidelines address clinical diagnosis, laboratory diagnosis, genetic counseling, related health problems, and behavior management across the lifespan.\n"
  },
  {
   "title": "Complications",
   "content": "Because the diagnosis has implications extending beyond the affected child, family members carrying a premutation should be evaluated for related conditions - premature ovarian failure and fragile X-associated tremor/ataxia syndrome - and offered appropriate genetic counseling given the risk to future pregnancies and other relatives.\n"
  }
 ],
 "clinical": [
  {
   "title": "When to Test for Fragile X Syndrome",
   "content": "Do not rely on physical examination alone to screen for fragile X syndrome in a young child, since the characteristic craniofacial features (long face, prominent forehead, prognathism, large ears) and macro-orchidism typically do not become apparent until the second decade of life, and macro-orchidism is rare before age 6. Instead, have a low threshold to order fragile X DNA (CGG-repeat) analysis in any boy presenting with unexplained developmental delay, especially when accompanied by social anxiety, hyperactivity, gaze aversion, perseverative language, hand biting, or marked sensory hypersensitivity. Also consider testing girls with unexplained developmental delay or autism-spectrum features, since about 30% of girls with the full mutation show cognitive effects, generally milder than in boys. Take a thorough family history specifically asking about intellectual disability, premature ovarian failure, and adult-onset tremor/ataxia in relatives, since these can reflect premutation carriage elsewhere in the family and should prompt cascade genetic counseling.\n"
  },
  {
   "title": "Managing a Child with Confirmed Fragile X Syndrome",
   "content": "Arrange a multidisciplinary approach centered on developmental and behavioral monitoring: routine primary care health supervision, ongoing input from a clinician experienced with fragile X syndrome, and connection to educational and behavioral health resources in the community. Anticipate and screen for associated findings - hyperextensible joints, mitral valve prolapse, and macro-orchidism developing around puberty - as part of routine follow-up rather than waiting for symptoms to prompt evaluation. Extend genetic counseling to the family once a diagnosis is confirmed, since the finding has implications for other relatives who may carry a premutation and be at risk for premature ovarian failure or fragile X-associated tremor/ataxia syndrome, and since future pregnancies in the family carry recurrence risk shaped by the anticipation phenomenon (repeat expansion through maternal transmission).\n"
  }
 ]
}